Effectiveness of maternal pertussis vaccination in England: an observational study

Gayatri Amirthalingam1, Nick Andrews2, Helen Campbell1

  • 1Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, UK.

PubMed

Insights

The pertussis vaccination program for pregnant women in England demonstrated high vaccine effectiveness, significantly reducing infant cases and hospitalizations. This maternal immunization strategy offers crucial protection for newborns against pertussis.

Area of Science:

  • Immunology
  • Public Health
  • Epidemiology

Background:

  • England introduced a pertussis (whooping cough) vaccination program for pregnant women in October 2012.
  • This initiative was a direct response to a pertussis outbreak across England.
  • The study aimed to evaluate the effectiveness of this vaccination program in preventing infant pertussis.

Purpose of the Study:

  • To assess the vaccine effectiveness of maternal pertussis immunization.
  • To determine the overall impact of the vaccination program on infant pertussis incidence and hospitalizations.
  • To provide data for international policymakers regarding maternal vaccination strategies.

Main Methods:

  • Analysis of laboratory-confirmed pertussis cases and hospital admissions in infants (January 2008–September 2013).
  • Data sourced from Public Health England's enhanced pertussis surveillance.
  • Vaccine effectiveness calculated by comparing maternal vaccination status in confirmed infant cases against national vaccine coverage data (Clinical Practice Research Datalink).

Main Results:

  • A significant decline in pertussis cases and hospitalizations was observed following the program's introduction, particularly in infants under 3 months.
  • Infants under 3 months experienced a 78% reduction in confirmed cases and a 68% reduction in hospitalizations in the first 9 months of 2013 compared to 2012.
  • Maternal vaccine coverage reached 64%, with calculated vaccine effectiveness of 91% for infants under 3 months and 90% for infants under 2 months.

Conclusions:

  • The maternal pertussis vaccination program in England is associated with high vaccine effectiveness.
  • Infant protection is likely achieved through both passive antibody transfer from mothers and reduced maternal exposure to pertussis.
  • The findings offer valuable insights for global public health strategies concerning pertussis prevention in infants.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
43.9K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
62